NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism.
NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA.
The main application is the engineering of recombinant proteins like antibodies or enzymes for better therapies.
Company Details
- Employees
- 5
- Founded
- 2012
- Address
- Av Charles Flahault, Montpellier,34000,france
- Phone
- 33 411759617
- co****@****syn.com
- Industry
- Biotechnology
- Website
- nanomedsyn.com
- Keywords
- therapeutis targeting, lysosomal storage diseases, therapeutic antibodies, nanoparticles adressing.
- HQ
- Montpellier
Nanomedsyn Questions
Nanomedsyn's helpline number is 33 411759617
Nanomedsyn's website is nanomedsyn.com
Nanomedsyn's LinkedIn profile is https://fr.linkedin.com/company/nanomedsyn
Nanomedsyn has
5 employees.
View email and phone details for 5
employees at Nanomedsyn.
Nanomedsyn's industry is
Biotechnology
Nanomedsyn's top competitors are
Laboratoire Jaldes,
Novapharm,
Ai-Biopharma,
Vigipharm,
Medincell,
Id Solutions,
Pharmablue,
Azelead,
Pharmya,
Sensorion.
Nanomedsyn's support email address is contact@nanomedsyn.com
Nanomedsyn's categories are Biotechnology
Nanomedsyn's founding year is 2012
